Clasado Biosciences (‘Clasado’), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has announced the appointment of Lucie Nagy as Head of Regulatory and Legal.
As the business continues to expand around the world, Lucie will spearhead the company’s developments in compliance, regulatory and legal affairs. Her strong experience working with brands across the life sciences sector will be put to good use within the business, which focuses on providing brands, formulators and food product developers with science-backed gut health ingredients that appeal to today’s consumer.
In the role, Lucie will oversee how the science behind the company’s flagship prebiotic ingredient Bimuno is communicated across key commercial markets, ensuring that regulatory compliance remains front and centre for the business. Lucie will also guide regulatory strategy for the business, ensuring that timely reporting, submissions and developments are clearly communicated with key stakeholders.
Per Rehné, CEO at Clasado, commented: “We are delighted to welcome Lucie to our team as we continue to grow. As a leader in microbiome science, our customers rely on us to stay well ahead of the regulations. Lucie’s keen attention to detail and experience in supporting supplement brands and functional food developers makes her an ideal fit for our team. We can’t wait to see her make her mark.”
Clasado’s leading brand Bimuno® is a powerful and versatile prebiotic. It is supported by over 90 scientific publications, including more than 20 clinical trials, and is the most studied prebiotic of its kind.
Commenting on her appointment, Lucie said: “It’s a fascinating time to be operating in the gut health market. Around the world, consumers are becoming much more proactive with their wellbeing, which offers incredible commercial opportunities for brands to include prebiotics within their product ranges. In my role as Head of Regulatory and Legal, I will be working closely with the science and marketing divisions of the business to really drive home what makes Clasado unique in the market and ensure that the standard of regulatory excellence at the company is maintained.
“As a pioneer and leading innovator in galactooligosaccharide (GOS) technology, the business has the expertise and scientific portfolio to bring about real sector change and I look forward to playing my part in that journey.” To find out more about Clasado Biosciences, please visit www.clasado.com